Galmed Pharmaceuticals (GLMD) Competitors

Sonoma Pharmaceuticals (NASDAQ:SNOA) and Galmed Pharmaceuticals (NASDAQ:GLMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, community ranking, media sentiment and valuation.

Which has better valuation and earnings, SNOA or GLMD?

Sonoma Pharmaceuticals has higher revenue and earnings than Galmed Pharmaceuticals. Sonoma Pharmaceuticals is trading at a lower price-to-earnings ratio than Galmed Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonoma Pharmaceuticals	$13.97M	0.33	-$4.84M	-$4.02	-0.71
Galmed Pharmaceuticals	N/A	N/A	-$6.91M	-$16.66	-0.10

Is SNOA or GLMD more profitable?

Galmed Pharmaceuticals has a net margin of 0.00% compared to Sonoma Pharmaceuticals' net margin of -26.82%. Galmed Pharmaceuticals' return on equity of -28.75% beat Sonoma Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonoma Pharmaceuticals	-26.82%	-68.98%	-26.39%
Galmed Pharmaceuticals	N/A	-28.75%	-24.98%

Which has more risk & volatility, SNOA or GLMD?

Sonoma Pharmaceuticals has a beta of 1.56, meaning that its stock price is 56% more volatile than the S&P 500. Comparatively, Galmed Pharmaceuticals has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500.

Does the media favor SNOA or GLMD?

In the previous week, Galmed Pharmaceuticals had 1 more articles in the media than Sonoma Pharmaceuticals. MarketBeat recorded 4 mentions for Galmed Pharmaceuticals and 3 mentions for Sonoma Pharmaceuticals. Sonoma Pharmaceuticals' average media sentiment score of 0.54 beat Galmed Pharmaceuticals' score of 0.12 indicating that Sonoma Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sonoma Pharmaceuticals	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Galmed Pharmaceuticals	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community prefer SNOA or GLMD?

Galmed Pharmaceuticals received 226 more outperform votes than Sonoma Pharmaceuticals when rated by MarketBeat users. However, 67.50% of users gave Sonoma Pharmaceuticals an outperform vote while only 63.05% of users gave Galmed Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Sonoma Pharmaceuticals	Outperform Votes 216 67.50%	Underperform Votes 104 32.50%
Galmed Pharmaceuticals	Outperform Votes 442 63.05%	Underperform Votes 259 36.95%

Do institutionals & insiders believe in SNOA or GLMD?

2.0% of Sonoma Pharmaceuticals shares are held by institutional investors. Comparatively, 76.1% of Galmed Pharmaceuticals shares are held by institutional investors. 3.9% of Sonoma Pharmaceuticals shares are held by insiders. Comparatively, 19.8% of Galmed Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Galmed Pharmaceuticals beats Sonoma Pharmaceuticals on 8 of the 14 factors compared between the two stocks.